Topadur Pharma AG Verified listing Verified listing

  • Swiss Biotech Association
    Member

Topadur Pharma AG (Schlieren, Zurich) is a clinical-stage biotech company developing small-molecule therapies that target impaired microcirculation and tissue regeneration. Its proprietary DualTOP® platform combines complementary pharmacological activities in single molecules for local use.

Products, services, technology

The lead compound TOP-N53 is in a Phase 2a study for digital ulcers in systemic sclerosis and has orphan designation in the US and the EU. TOP-M119 for alopecia, co-developed with Oshen Holdings, is in IND-enabling studies.

Cooperation possibilities

Topadur welcomes partnering discussions.

Location

Canton

Facts & figures

  • Type of organization
    Private company
  • Year of foundation
    2015
  • Number of employees in Switzerland
    10-19

Key business

Core competencies

You may also be interested in